Skip to content
Screener

BioLife Solutions BLFS CryoStor — Concentration risk (in percent)

Similar metrics at other companies

Dine Brands Global logo
DINDomestic — Concentration risk (in percent)
6.1%+0.1pp
Ready Capital logo
RCOther — Concentration risk (in percent)
0.7%+0.3pp
Finance of America Companies logo
FOAOther — Concentration risk (in percent)
10%0.0pp
Altisource Portfolio Solutions logo
ASPSOrigination — Concentration risk (in percent)
0%
Procter & Gamble logo
PGBeauty — Concentration risk (in percent)
9%0.0pp
Procter & Gamble logo
PGGrooming — Concentration risk (in percent)
8%0.0pp

Other financials

Income statement

See full
Revenue$28.5M+21.5%
Gross profit$18.3M+20.0%
Operating income$1.7M+111%
Net income$45.1M+385%
EPS (diluted)$0.91+376%

Balance sheet

See full
Cash & equivalents$24.0M-24.8%
Total debt$15.7M-33.9%
Total equity$420.0M+21.0%
Total assets$447.5M+15.6%

Cash flow

See full
Operating cash flow$6.3M-13.8%
CapEx$1.0M-40.2%
Free cash flow$5.3M-5.7%

Valuation

See full
Market cap$1.7B+56.2%
Enterprise value$1.69B+56.7%
P/E54.6×
P/S16.5×+3.3×

Profitability

See full
Gross margin67.2%
Operating margin1.6%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio9.7×+5.3×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.

The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:22 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054355
Product revenue concentrationThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
CryoStor84%80%83%82%

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is BioLife Solutions's cryostor — concentration risk (in percent)?
BioLife Solutions (BLFS) reported cryostor — concentration risk (in percent) of 84% in Q2 2026.
How has BioLife Solutions's cryostor — concentration risk (in percent) changed year-over-year?
BioLife Solutions's cryostor — concentration risk (in percent) increased by 5.0% year-over-year, from 80% to 84%.
What is the long-term trend for BioLife Solutions's cryostor — concentration risk (in percent)?
Over 2 years (2023 to 2025), BioLife Solutions's cryostor — concentration risk (in percent) has grown at a 19.4% compound annual growth rate (CAGR), from 174% to 248%.
What does cryostor — concentration risk (in percent) mean?
This metric measures the percentage of total segment revenue derived from a limited number of key customers or specific high-value contracts. A higher concentration indicates increased vulnerability to the loss of a major client or shifts in their procurement strategy. Monitoring this ratio helps assess the stability and diversification of the revenue stream within the biopreservation product line.

Ask your AI about BioLife Solutions's cryostor — concentration risk (in percent).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude